series-a
Stage
1
Investors
About
Genesis Therapeutics develops AI-driven molecular design platforms to accelerate small molecule drug discovery through integration of foundational AI models and physics-based approaches.
Explore Genesis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.